Back to Search
Start Over
Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life.
- Source :
-
Applied health economics and health policy [Appl Health Econ Health Policy] 2023 Sep; Vol. 21 (5), pp. 761-771. Date of Electronic Publication: 2023 May 27. - Publication Year :
- 2023
-
Abstract
- Background: Understanding the physical and mental health needs of the population through evidence-based research is a priority for informing health policy. During the COVID-19 pandemic, population wellbeing dramatically dropped. The relationship between experiences of symptomatic illness episodes and health-related quality of life has been less documented.<br />Objective: This study analysed the association between symptomatic COVID-19 illness and health-related quality of life.<br />Methods: The analyses drew from a cross-sectional analysis of data from a national digital symptoms' surveillance survey conducted in the UK in 2020. We identified illness episodes using symptoms and test results data and we analysed validated health-related quality of life outcomes including health utility scores (indexed on a 0-1 cardinal scale) and visual analogue scale (VAS) scores (0-100 scale) generated by the EuroQoL's EQ-5D-5L measure. The econometric model controlled for respondents' demographic and socioeconomic characteristics, comorbidities, social isolation measures, and regional and time fixed effects.<br />Results: The results showed that the experience of common SARS-CoV-2 symptoms was significantly associated with poorer health-related quality of life across all EQ-5D-5L dimensions of mobility, self-care, usual activities, pain/discomfort and anxiety/depression, a decrement in utility score of - 0.13 and a decrement in the EQ-VAS score of - 15. The findings were robust to sensitivity analyses and restrictive test results-based definitions.<br />Conclusion: This evidence-based study highlights the need for targeting of interventions and services towards those experiencing symptomatic episodes during future waves of the pandemic and helps to quantify the benefits of SARS-CoV-2 treatment in terms of health-related quality of life.<br /> (© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
Details
- Language :
- English
- ISSN :
- 1179-1896
- Volume :
- 21
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Applied health economics and health policy
- Publication Type :
- Academic Journal
- Accession number :
- 37243797
- Full Text :
- https://doi.org/10.1007/s40258-023-00810-y